+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biogen Inc. - logo

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

Immunology Market 2024-2028 - Product Thumbnail Image

Immunology Market 2024-2028

  • Report
  • August 2024
  • 176 Pages
  • Global
From
From
Dementia and Movement Disorder Treatment Market 2025-2029 - Product Thumbnail Image

Dementia and Movement Disorder Treatment Market 2025-2029

  • Report
  • June 2025
  • 228 Pages
  • Global
From
Protein Engineering Market Report 2025 - Product Thumbnail Image

Protein Engineering Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Biosimilars World Market - Product Thumbnail Image

Biosimilars World Market

  • Report
  • January 2023
  • 28 Pages
  • Global
From
From
From
Trigeminal Neuralgia (Tic Douloureux) - Global Clinical Trials Review, 2022 - Product Thumbnail Image

Trigeminal Neuralgia (Tic Douloureux) - Global Clinical Trials Review, 2022

  • Clinical Trials
  • February 2022
  • 96 Pages
  • Global
From
Drug Manufacturing Sector Scorecard - Thematic Intelligence - Product Thumbnail Image

Drug Manufacturing Sector Scorecard - Thematic Intelligence

  • Report
  • October 2022
  • 23 Pages
  • Global
From
From
Stem Cell Therapy Market Report 2025 - Product Thumbnail Image

Stem Cell Therapy Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Loading Indicator